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Complement is bound when an appropriate antibody reacts with its antigen 
or when it is nonspecifically aggregal:ed by heat or chemical means; no signi- 
ficant binding occurs with the isolated antibody (1). It is therefore likely that 
the interaction of the first component of the complement sequence with anti- 
body is  due  to  intramolecular  conformational  changes  within  the  antibody 
molecule, or to intermolecular association of several molecules, or to a combina- 
tion of both phenomena. 
In the usual interaction between antibody and complex antigens and in the 
production of nonspecific aggregates, an ill-defined product is formed in which 
it is difficult to investigate the physical changes which have occurred in  the 
antibody molecule.  The  need  for  a  more  easily  characterized  material  was 
recognized by Valentine and Green, who succeeded in reducing the molecular 
complexity by using a  divalent hapten of minimum length to form polymers 
with specific IgG antibody (2). 
By electron microscopy they showed that the product of this reaction was a 
mixture of dimers,  trimers,  tetramers, pentamers,  and some higher polymers. 
An  attempt has  therefore been made  to fractionate this mixture and  to test 
the complement-fixing efficiency of tile different-sized polymers to determine if 
the ability to bind complement coukl be correlated with size.  The results sug- 
gest  that  dimers  and  trimers  cannot fix  complement  or  Ci,  but  higher  ag- 
gregates can. 
* Dr. Hyslop was the recipient of a Moseley  Travelling Fellowship of the Harvard Medical 
School, Boston, Massachusetts from 1968 to 1969. His present address is: Infectious Disease 
Unit, Massachusetts General Hospital, Boston, Massachusetts 02114. 
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Materials and Methods 
Bis-Dinitrophenyl  (DNP)l-Octamethylene-Diamine.--Fluorodinitrobenzene  (4 mmoles, 0.76 
g) was dissolved in ethanol (20 ml) and added with stirring to octamethylenediamine (2 mmoles 
in 5 ml 1 ~r NaHCO3). The mixture was stirred for 2 hr and the resulting precipitate filtered 
and crystallized from ethyl acetate, mp  134-5°C.  The water-insoluble bivalent hapten  (cal- 
culated for  C20H24N6Os:C,  50.0%;  H,  5.0%;  N,  17.5%;  found  C,  50.2%;  H,  4.90%;  N, 
17.9%) was soluble in dimethylformamide. 
EpMlon-DNP-aminocaproic acid was prepared by the method of Carsten and Eisen (3). 
Preparation  of  Purified  Rabbit Anti-DNP  Antibody.--Anti-DNP  was  prepared  using 
DNP-BGG according to  Farah,  Kern,  and Eisen (4)  and the following schedule employed 
in  immunizing normal rabbits: a  primary  injection subcutaneously distributed  among  the 
four legs of 5 mg BGG-DNP in 2 ml of 50% water-in-oil emulsion containing Difco complete 
Freund's  adjuvant  (Difco  Laboratories,  Inc.,  Detroit,  Mich.)  was  followed  by  a  booster 
injection at 6 wk of the same volume of 50% complete adjuvant emulsion containing 1 mg 
of BGG-DNP. Thereafter, weekly bleedings were made from the marginal vein of the ear. 
Sera were collected after clotting overnight by centrifugation at 2500 g for 1 hr. A washed 
immune precipitate  prepared  at  equivalence from  pooled  antisera with  dinitrophenylated 
bovine serum albumin was solubilized in 0.1  •  2,4-dinitrophenol which was then displaced 
by dialysis against para-nitrophenol  by the method  of  Hong and Nisonoff  (5).  The para- 
nitrophenol was  removed  from  the  final  antibody  solution  by  gel  filtration on  Sephadex 
G-25  (Pharmacia  Fine  Chemicals,  Inc.,  Piscataway,  N.J.)  equilibrated  with  0.20  M Tris 
HC1,  pH  8.0. 
The OD of the final antibody solution was 3.0 at 280 m/z and 0.070 at 360 m/z; in estimating 
_1%  the amount  of  purified  antibody,  an  L2s 0  =  16  and  a  molecular weight  of  150,000  were 
assumed. The number of available combining sites per mole for the preparation used through- 
out these studies was  1.0 as determined in fluorescence titration with episilon-DNP-amino- 
caproic acid under the conditions specified below. From this standard antibody preparation a 
concentrated solution containing 9.8 mg/ml antibody protein was made by negative pressure 
ultraflltration in Visking dialysis tubing; this solution was used for forming hapten-antibody 
complexes with the synthetic bivalent hapten  bis-DNP-octamethylene  diamine at "fluores- 
cence equivalence" for gel filtration column chromatography. 
Fluorescence Titration  of Anti-DNP  Antibody  with  Epsilon-DNP  Aminoeaproate.--The 
activity of  the purified antibody was determined by fluorescence titration (6)  with epsilon- 
DNP-aminocaproate  using the apparatus  described  by  Green  (7).  All fluoresence readings 
(at 25°C) were made relative to a standard solution of 10  -6 ~  N-acetyltryptophanamide. The 
antibody solution (20 #g/ml) was titrated by addition of 2-#1 portions of a 20-#M solution of 
epsilon-DNP-aminocaproate  with  continuous  magnetic  stirring.  The  maximal  quenching 
observed in the presence of 2 X  10  -7 ~  free hapten was 55%, and the calculated equivalence 
was 1 combining site per mole of antibody with a  dissociation constant of 3  X  10  -9 M. The 
antibody was greater than 90% precipitable by DNP-bovine serum albumin (BSA)  despite 
the relatively low activity found on fluorescence titration. 
As fluorescence titration was performed at an antibody concentration of  about  10  -7 ~, 
the discrepancy between calculated available combining sites and the observed precipitable 
activity of the purified antibody was assumed to be due to partial titration of antibodies of 
1  Abbreviations used in this  article: BSA,  bovine serum  albumin; BGG,  bovine gamma 
globulin; C-EDTA,  complement ethylenediaminetetraacetate; DNP,  dinitrophenyl; EDTA, 
ethylenediaminetetraacetate; TCB, Tris complement buffer; TCB-EDTA,  Tris complement 
buffer-ethylenediaminetetraacetate; TCB-S, Tris complement buffer with sucrose; TCB-S-A, 
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dissociation constants in excess of  10  -7  M which would  also  account for  the relatively re- 
duced maximal quenching value. 
Reaction of Bis-DNP-Octamethylene-Diamine  with  Anti-DNP.--To  a  1.5-ml  volume  of 
purified anti-DNP  antibody in 0.20  ~  Tris,  pH  8.0,  containing  14.7  mg of  antibody was 
added with immediate mixing 0.15 ml of a  dimethyl-formamide (British Drug Houses, Ltd.) 
solution  containing  54.9  nanomoles  of  bis-DNP-octamethylenediamine  which  represented 
reaction at fluorescence equivalence. No precipitate or opalescence was observed. The reagents 
were allowed to react for 30 min at room temperature and then the entire sample applied to 
the Sepharose column at 4°C.  After chromatography overnight, column fractions were kept 
in the cold. 
Preparation  of Antibody-Hapten  Complexes for Sedimentation  Measurements.--Bis-DNP- 
octamethylenediamine (30  #1 of a  2-ram  solution in dimethylformamide) was added  slowly 
from a  microsyringe, with constant stirring, to  a  solution of rabbit high-affinlty anti-DNP 
antibody (12 mg in 1.0 ml of 0.1 ~  sodium phosphate buffer, pH 7.4). Previous titration of 
the antibody with epsilon-DNP-aminocaproate had shown that this was  sufficient to  give 
90% saturation of the calculated binding sites. The solution was used on the same day for 
measurements of sedimentation velocity. Sedimentation velocity was determined in a Spinco 
Model E  analytical ultracentrifuge at 59,780  rpm.  Pooled samples of antibody-hapten com- 
plexes fractionated in Tris  complement buffer  (TCB)  on  Sepharose  (see  below)  were con- 
centrated by ultrafiltration for sedimentation velocity studies. 
Agarose Gd Filtration Column Chromatography.--A glass column with adjustable ends was 
packed under 1 meter hydrostatic pressure head with Sepharose 4B  (Pharmacia Fine Chem- 
icals, Inc.)  in TCB  (see  section on buffers)  to give final bed dimensions of  143 cm by 1.5 
cm diameter; under reverse direction flow and a net pressure of 150 cm of water, a flow rate 
in the cold of 10 ml/hr was attained. Sample volumes of 1.25 ml were collected. This column 
retained its flow  and separation characteristics for 6  months.  (When the column was equi- 
librated with Trls complement buffer with sucrose (TCB-S)  for studies of C1  fixation, a  shift 
was noted in the elution profile towards larger ehition volumes without alteration of the total 
volume occupied by the fractionated antigen-antibody complexes  ). All preparations described 
in the present report were prepared on this column using 14.7  mg of antibody mixed with 
divalent hapten in  1.6  ml total volume,  although equivalent fractionation was successfully 
obtained on a shorter column (73.5 >( 1.5 cm gel bed) of Sepharose 6 B using smaller amounts 
of antibody-hapten complexes (1.5 mg in 1.0 ml). 
Electron microscopy.  -The technique of  negative  staining  on  carbon  grids  with  sodium 
silicotungstate developed by Valentine (8,  19)  was employed both on samples chosen from 
individual column fractions and on pooled fractions which had been concentrated by nega- 
give pressure ultrafiltration. An E2s0 of about 0.100 was optimal, since it insured sufficient 
protein to produce even spreading of the negative stain without overcrowding the images of 
the molecules.  Samples in TCB  and TCB-S  (see  section on buffers) could be used directly 
without change of buffer. Best results were obtained when samples to be studied were kept 
cold at all times and examined within a day. The samples were examined in a Phillips E. M. 
200 electron microscope at a magnification of 55,000. 
Preparation of Hemolysin and Complement.  Rabbit hemolysin was prepared using erythro- 
cyte stromata made according to Mayer from sheep erythrocytes (Wellcome Reagents, Ltd., 
Wellcome Research Laboratories, Beckenham, England) to immunize normal rabbits by the 
intravenous route, following the recommended schedule designed to produce antibodies of the 
IgM class  (9,  10).  The immune sera were decomplemented at 56°C  for 30 min before dis- 
pensing in 1.0-ml portions into vials for freezing at --20°C. Whole complement was prepared 
by bleeding under ether inhalation anaesthesia normal Hartiey-strain guinea pigs by cardiac 
puncture and allowing the blood to clot at 4°C for 2 hr before separation by centrifugation 
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treatment to  be used as a  source of whole complement or were processed immediately in 
preparing functionally pure C1 and C2 (see below). 
Rabbit hemolysin was titered in 5.0-mI reaction volumes with 1 X  109 cells and  guinea 
pig complement in 7.5-1111 reaction volumes with 5 X  10 s cells according to the methods of 
Mayer (9). 
Buffers  Use~ in  Complement St  udies.--Erythrocytes  were washed in phosphate-buffered 
saline  (0.145 ~  NaC1, 0.05  ~  PO4,  pH  7.4),  followed  by  Tris  complement buffer  [TCB; 
0.05  :~  Tris  (hydroxymethyl) methyl  amine  (AnalaR,  British  Drug  Houses, Ltd.,  Poole, 
Dorset, England), 0.04  M HC1, 0.00015  M CaCI2,  0.0005 M MgCl2,0.098 ~t NaC1, pH 7.5] 
which had an ionic strength of 0.139 and an osmotic strength of 286.2 milliosmoles  per liter, 
and was used in place of Veronal-buffered saline for hemolysin and complement titrations. 
For  storage  of  C1  and  C2  preparations and  all  reactions  requiring  low  ionic  strength- 
isoosmotic conditions, Tris complement buffer with sucrose and albumin (TCB-S-A)  was used 
[0.05 M Tris, 0.04 ~  HC1, 0.00015 B~ CaC12,0.0005 M MgCI~,  0.025 M NaC1, 0.146 M sucrose, 
(AnalaR), pH 7.5, 0.1 g/100 ml bovine serum albumin (BSA)  (Sigma Chemical Co., St.  Louis, 
Mo.); /~  ~  0.066, 286.3 milliosmoles per liter]. TCB-S is identical to TCB-S-A with albumin 
omitted. Complement ethylenediaminetetraacetate (C-EDTA) was prepared by appropriate 
dilutions of whole complement with ice-cold Tris complement buffer-EDTA (TCB-EDTA) 
which was free of Ca and Mg and contained 0.05  ~t Tris, 0.04  M HC1, 0.098 ~  NaC1, and 
0.01  ~[ EDTA  [ethylenediaminetetraacetic acid, disodium salt  (AnalaR);  stored as a  0.1 
stock solution which had been adjusted to pH 7.5 with 2 ~  NaOH]; pH of buffer was 7.5. 
(For convenience in storage of buffers,  five-fold concentrates of TCB, TCB-S, and Ca-Mg- 
free-TCB were normally prepared). A  0.0955 M solution of sodium carbonate was used in 
photometric standardization of erythrocyte suspensions (9) and a citrate-saline "stop reagent," 
0.015  M in  sodium  citrate and 0.150  in  NaC1, was used in  hemolysin titrations. Acetate, 
phosphate, saline-acetate,  and  ammonium  sulphate buffers used in preparation of  C2 fol- 
lowed the directions of Nelson et al.  (11) except that ionic strengths were adjusted by con- 
ductivity  measurements at  room  temperature  against  room  temperature  standard  NaC1 
solutions. 
Method o/Complement Fixation Assay.--The method of Wasserman and Levine (12) was 
modified as follows: Two-fold dilutions in TCB of the sample to be studied for complement 
fixation (C-fixation)  were prepared, and 4.0 ml of a complement dilution in TCB  containing 
0.4  CHs0  units per ml was added to  1.0 ml volumes of  each of  the  sample dilutions and 
appropriate controls  (C-fixation  blank,  pro-  and  anticomplementary  effects,  and  comple- 
ment color)  and allowed to react overnight at 4°C.  The following  day 2.0 ml of optimally- 
sensitized sheep erythrocytes (9) in a concentration of 2.75  X  l0 s cells per ml were added to 
each tube and  to cell fragility and complete hemolysis controls (latter made with distilled 
water)  and the reaction mixtures incubated for 90 rain at 37°C.  After centrifugation in the 
cold,  the optical density of the supernatants  (warmed to  room  temperature)  was read  at 
541 m/~ with a  1 cm light path in a  Uuicam SP500 spectrophotometer (Unicam Instruments 
Ltd.,  Cambridge, England)  and  the difference  calculated in optical density units  between 
the degree of hemolysis in the C-fixation blank and sample tubes. To determine in  OD  541 
units the amount of complement fixed by an individual sample, the difference values for the 
tubes showing 30-80% hemolysis (viz. the linear range of partial hemolysis)  were multiplied 
by their dilution factors. On this basis each OD541 unit represented approximately 2  CH~0 
units of complement fixed. As shown in the Results section, the validity of this method was 
confirmed by the dose-response curve shown in Fig. 7~ which shows a linear relationship be- 
tween protein concentration and  amount of complement fixed.  The slope of the curve ob- 
tained reflected the C-fixlng efficiency of the individual preparations studied. 
Preparation of Partially Purified Complement Components.--C1 was prepared from whole 
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(13, 14) without the gel filtration step; the final precipitate was dissolved in TCB-S-A, clarified 
by ultracentrifugation, the supernatant dispensed as  1.0-ml portions  into vials,  and stored 
at -  20°C. 
C2 was prepared according to Nelson et al (11)  from the fourth  (NH4)2SO4  precipitate 
by  CM-cellulose  column  chromatography  (Whatman  CM  32,  H.  Reeve  Angel  and  Co., 
London), using for 100 ml of solubilized and dialyzed material a packed total bed volume of 
150 cc contained in a  5 cm diameter column with an effective head of 1 meter. Under these 
hydrostatic conditions, flow rates of 100--200 ml per hr were achieved. The effluents containing 
the highest optical density at 280 m/z and representing 110 %  of the applied sample volume 
were pooled and the pH  adjusted to 6,0 with 0.15 N NaOH  before dispensing into vials in 
1.0-ml portions for freezing at  --20°C.  (A significant decay  in  titers  of  both  purified  Ci 
and  C2  was  observed over a  3-month interval at  this storage  temperature.)  Dilutions  of 
C2 were made in TCB-S-A. 
Both Ci and C2 prepared by these methods were functionally pure. 
Molecular Titrations of  C] and  C2.--EAC14  were  prepared  using  sheep  erythrocytes 
which were washed thrice with TCB-EDTA,  thrice with TCB, sensitized with a  1:50 dilu- 
tion in TCB of rabbit hemolysin at room temperature for 15 min, washed and resuspended 
in TCB-S, cooled and reacted at 0°C for 10 rain in a concentration of 1 X  109 cells/ml with 
1.0 ml of unabsorbed whole complement for each 40 ml of suspension, washed twice in the 
cold and resuspended in TCB-S-A, incubated at 37°C for 90 min, washed and finally stored 
ill TCB-S-A at 4°C  where suspensions were stable for approximately  1 wk,  and exhibited 
a tmax of 4--5 mill with functionaUy pure C2 (15). 
EAC4 were prepared after the method of Borsos and Cooper  (16)  from  freshly prepared 
EAC14 cells of known tmax by a  10min incubation at 37°C in TCB-EDTA  buffer contain- 
ing 0.1  g  %  BSA followed by washing with the same buffer,  two cold washes with  TCB 
containing 0.1 g %  BSA, and final storage at 4°C in a suspension of 1 X  109 ceUs/ml in  the 
same buffer. EAC4 prepared and stored in this manner were stable for at least 2  wk  without 
added antibiotics, showed less than 1%  hemolysis in assay controls for fragility, exhibited 
a tm,x of 4-8  rain with limiting C2  when converted  to  high multiplicity SAC14  with ex- 
cess C1  (15,  17),  and demonstrated at least 40  rain  of  plateau  at  maximal  SAC142  with 
limiting SAC14  and  excess  C2  to reproduce conditions used for Ci  titrations according to 
Borsos and Rapp (18). 
C2 titrations were performed according to the method of Borsos,  Rapp,  and  Mayer (15) 
with EAC14 with the exception that reactions were conducted in TCB-S-A up to the addition 
of C-EDTA. 
C1  titrations using EAC4  and excess  C2  were  done as  described  by Borsos  and  Rapp 
(18),  substituting TCB-S-A for Veronal-buffered saline-sucrose. 
C1 Fixation Assay.--To  0.5  ml of undiluted column fractions  in  TCB-S  and  controls 
was added  0.5  ml  of  Ci  diluted in ice-cold  TCB-S-A  to  contain  approximately  1.2  CHs0 
units;  the conditions studied  for  optimizing  Ci  fixation are  described  under  Results.  In 
the final system adopted, the mixture of sample and C1 was held at 0°C  until all tubes were 
prepared,  then incubated at 30°C  for  10 rain, followed by the addition at  15 sec intervals 
(and with immediate mixing) of 0.5 ml containing 7.5  X  107 EAC4  (equilibrated  to  30°C). 
Each tube was incubated with EAC4 for exactly 15 mill and then removed from  the water 
bath, mixed immediately with 3.0 ml of ice-cold TCB-S-A, held at 0°C until the remaining 
tubes were completed,  and  then centrifuged at 3°C  for  5  rain at 300 g.  The supernatants 
were carefully aspirated as completely as possible without removing cells which were  then 
resuspended in 1.0 ml of cold TCB-S-A and held at 0°C until all tubes were processed. After 
10-min equilibration at 30°C,  at 15-sec intervals each tube was mixed with 0.5 ml of warm 
C2 in sufficient molecular excess to  sustain maximal  SAC142  multiplicity.  After  a  10-rain 788  C  AND  C1  FIXATION BY  HAPTEN-ANTIBOD¥  COMPLEXES 
incubation with C2, each tube was removed and 6.0 ml ice-cold C-EDTA (1:50)  added,  and 
held at 0°C until all tubes completed.  The entire set of tubes was  then incubated  for  90 
rain at 37°C, followed by centrifugation  at 3°C for 5 rain at 600 g. The supernatants were al- 
lowed to warm to room temperature before reading the optical density at 412 m#. 
Controls were included  for  cell fragility, specificity  of hemolysis  (EAC4  +  C1  +  C2; 
EAC4  +  C1 +  C-EDTA;  EAC4  +  C2  +  C-EDTA;  EAC4 +  C-EDTA),  complement 
color, and complete hemolysis (EAC4 +  distilled  water). Specific partia  1  hemolysis  (EAC4  + 
C1  +  C2  +  C-EDTA) controls  were interspersed  among  the  sample  tubes to allow  cor- 
rection for Ci  decay.  The amount of C1  fixed by an individual sample was  calculated by 
subtracting the observed z value (18) from appropriate control value which  had  been  cor- 
rected for time-dependent C1  decay. 
RESULTS 
Size  Distribution  of Antibody-Hapten  Complexes.--The  complexes  formed 
when  the  binding sites were  saturated  with  bivalent hapten  were  studied  by 
electron  microscopy  and  analytical  ultracentrifugation.  Electronmicrographs 
Fro.  1.  Sedimentation  of complexes  of  rabbit  anti-DNP  antibody and  bis-DNP-octa- 
methylene-diamine  after reaching  top speed,  a,  11  rain;  b, 27 rain;  c, 43  rain; d, 59 rain. 
Base angle 60  ° for a and b, 50  ° for c and d. 
of  the  unfractionated  mixture,  published  elsewhere  (2,  19,  20),  showed  pre- 
dominantly cyclic polymers containing from 2 to 12 or more antibody molecules; 
open chain forms and monomers were also present.  The molecules were linked 
together  through  the  bivalent  hapten  by  their  Fab  fragments,  and  the  Fc 
fragments, identified by their susceptibility to pepsin digestion, could be partic- 
ularly well seen as small projections at the corners of the polygonal shapes.  On 
counting the individual forms in various plates, the most common species were 
dimers  and  trimers,  their contribution on  a  weight basis to  the total mixture 
being  as  much  as  30-50%. 
The  results  of  a  sedimentation  velocity experiment  on  the  unfractionated 
mixture are shown in Fig.  1.  The major peak (s20.w 9.9)  accounted  for  about 
25 % of the total protein and indicated that a dimer composed of hapten linking 
two  7S  molecules was  the  predominant  species.  The  remaining protein apart 
from  a  small 7S  peak sedimented  as  a  broad region comprising a  mixture  of 
species with sedimentation constants in the region of 12-20S. HYSLOP, DOURMASHKIN, GREEN, AND PORTER  789 
Repetition  of the analysis after addition  of epsilon-DNP-aminocaproate to 
the bivalent hapten-antibody mixture to a final monovalent hapten concentra- 
tion of 0.01  M gave a  single peak of s20.w 6.7,  consistent with complete depo- 
lymerization of the polymers in the presence of monovalent hapten. 
Separation of Antibody-Hapten Complexes of Varying Size  by Agarose Gel 
Filtration.--When  the whole mixture of antibody-hapten complexes formed at 
fluorescence  equivalence  was  subjected  to  gel  filtration  on  Sepharose  4B  as 
shown in Fig. 2, an effluent profile of protein concentration was obtained which 
was similar to the Schlieren pattern seen in the ultracentrifugal analysis of the 
unfractionated mixture (cf. Fig.  la). It can be seen from Fig. 2 that two over- 
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FIG.  2.  Chromatography of  antibody-hapten complexes on  a  column  of  Sepharose 4B. 
The elution profile of rabbit  anti-DNP  alone (dotted line) is compared with  the  elution 
profile of the  same antibody  after reaction at fluorescence equivalence with  the  bivalent 
hapten. The small terminal peak of the latter profile (solid line) is due to absorption at 280 
m/~ by the hapten solvent dimethylformamide. 
lapping components were present under the main peak, one of which with an 
elution volume of 205 ml directly overlay the effluent profile of the monomeric 
IgG marker. When fractions from the  181-185-ml  region  at  the  apex of  the 
larger peak were pooled and concentrated,  the observed s20,~ of 8.7  was inter- 
preted as representing the  average sedimentation rate of a  mixture of dimers 
and monomers of IgG. Under the conditions of low speed  (31,410  rpm),  short 
duration  (2 hr), and low protein concentration used in this analysis, there was 
no  appreciable  resolution  of  this  apparently  homogenous  material  into  two 
components. 
Fractions 124-138-ml from the middle of the region presumed on the basis of 
their elution volumes to represent the larger complexes, were concentrated by 
ultrafiltration.  Ultracentrifugation  of this  material  gave a  broad,  diffuse low 
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Although the different polymeric species had not been completely separated 
from one another, the entire effluent profile and the elution volume of its in- 
dividual  identifiable  major  and  minor  peaks  remained  remarkably  constant 
from one fractionation to the next.  The relative proportions of the different 
fractions identified by gel filtration could be changed, however, by alteration in 
the proportions of hapten and antibody used in preparing the hapten-antibody 
mixture: both hapten excess and antibody excess led to a reduction in the num- 
ber of larger forms and a corresponding increase in the protein content of the 
fractions containing the dimer and monomeric forms. 
The  physical  stability  of  the  larger  forms  was  tested  by  concentrating 
separately fractions from the middle  region  of the  ascending portion of  the 
effluent profile and fractions from the main peak, and rechromatographing each 
independently.  In  both  instances  there  was  a  shift  towards  larger  elution 
volumes and, therefore, smaller forms than  predominant in the original source. 
It was concluded that some rearrangement can occur once the complexes have 
been  formed  but  that  any  rearrangement  leads  to  production  of  dimer  or 
monomeric configurations rather than genesis of larger polymeric rings. 
Electron~nicroscopy of Fractionated Antibody-Hapten  Complexes.--Electron- 
micrographs were made of concentrated pooled fractions as well as of individual 
fractions. The results were independent of the buffer used in eluting the com- 
plexes. As the low molecular weight peak of the elution profile coincided with 
the IgG marker, it was not examined in the electron microscope. 
The main peak (Fig. 3),  of s20,~ 8.7,  showed predominantly (80-90%)  rod- 
shaped dimers composect of IgG molecules doubly-linked by two molecules of 
bivalent hapten and in which the four Fab fragments appeared either as twe 
parallel bars or as a  single denser bar attributed to the effect produced by a 
lateral view (20). A number of monomers and trimers could also be identified in 
this fraction, but there were very few larger species. 
Material from the high molecular weight end of the chromatogram, such as 
the individual fraction at  110 ml  shown in  Fig.  4,  was  characterized by the 
prevalence of large rings or chains constructed from hapten and antibody (n 
6). Tetramers, trimers, and even a few dimers were also present, but in view 
of the ability of Sepharose to fractionate molecular species according to size, it 
is likely that most of these smaller forms resulted from slow rearrangement of 
larger polymers since the smaller rings  are favored by entropy factors.  This 
conclusion is supported by experiments in which pooled fractions from the same 
region of large polymers were concentrated by ultrafiltration and allowed to 
stand at room temperature for several hours (Fig. 5).  Such samples showed a 
great increase in the proportion of small rings at the expense of the larger ones 
and  explained  the  observed s20,~ of  13.5-16.0  for concentrates  of this  same 
region. 
Fractions emerging from the column between the dimer peak and the large 
polymer region shown in Fig. 4 were similar in size distribution to Fig. 5. Fla.  3.  Antibody-hapten  complexes from  the  main  protein peak  of  Fig.  2,  which 
do not fix complement (X  385,000,  scale marker  =  100 A). The predominant  species 
is a  dimer which shows a number of different profiles depending on the orientation of 
the two pairs of Fab fragments in the stain. Sometimes both pairs can be seen clearly 
as  two  almost  parallel  bars,  with  an  Fc fragment  at  each  end,  but  often  they  are 
superimposed  so that  only a  single bar is visible. In both  orientations  the length of 
the dimer is about 220 A. Monomers and trimers are also present. 
791 FIG. 4.  Antibody-hapten complexes  showing maximal complement fixation. Frac- 
tion of  110 ml elution volume, Fig. 2 (X  38,5,000, scale marker  =  100 A). The pre- 
dominant species are large linear or cyclic polymers. A number of trimers, tetrarners, 
and pentamers are also visible. 
792 FIG.  5.  Antibody-hapten complexes  from  the  region  of  maximal  complement 
fixation after  concentration and  storage  at  room  temperature.  The  proportion  of 
dimers and of  small  rings  has  increased  at  the  expense  of  the  larger  polymers. 
(X 385,000, scale marker =  100 A). 
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Complement-Fixing  Properties  of  Individual  Column  Fractions.--When  in- 
dividual fractions in Fig.  2 were tested directly for ability to fix whole guinea 
pig complement, as shown in Fig. 6, it was apparent that efficient complement 
fixation  was  confined  to  a  limited  range  of fractions  which  eluted  from the 
column in a  position consistent with sizes of complexes definitely larger than 
the dimer form (which itself showed very little  absolute  C-fixation). In other 
experiments  when  fractions  from  the  C-fixing  region were concentrated and 
rechromatographed, the elution position of the highly active  C-fixing fractions 
did not change,  although the effluent profile of protein concentrations became 
more symmetrical and underwent a shift towards a larger elution volume. 
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FIG. 6.  Complement-fixation  profile from Sepharose 4B gel-filtration in TCB of hapten- 
antibody  complexes. Every third  fraction  assayed. C-fixation values (Q)  for  individual 
fractions, expressed in OD~41 units, are compared with the  profile of protein concentration 
of the fractions (solid line). The specific activity  (A) was derived by dividing the  amount 
of complement fixed by the OD2s0 of the sample. 
Repeated experiments with C-fixation  analysis of chromatographed hapten- 
antibody  complexes  confirmed  the  limitation  of  expression  of  this  type  of 
biological activity to the fractions shown in Fig.  6,  and neither isolated dimer 
region material nor fractions obtained from rechromatography of concentrates 
of the dimer region showed significant  C-fixation. 
Dose-Response  Studies  o]  C-Fixation  by Complexes.--To  test independently 
the validity of the specific activity plot in  Fig.  6,  dose-response experiments 
were performed by comparing amounts of complement fixed by varying amounts 
of isolated complexes from small pools of fractions from the  complement-fixing 
region. The dose-response curve illustrated in Fig. 7 is from one such experiment 
performed with material from a region of particularly high specific activity.  In 
each instance  a linear response which passed through the origin was obtained HYSLOP~  DOURMASIIKIN, GREEN, AND  PORTER  795 
with all C-fixing species but the slope for individual preparations varied as one 
would predict from differences in specific activity. 
Specificity of Complement Fixation by Polymeric Forms of Hapten-Antibody 
Complexes.--Inhibition  by monovalent hapten  of  C-fixation was  studied  by 
allowing 1.0-ml portions of a dilution  (containing 0.05  nanomoles of antibody 
and  capable  of fixing  approximately 1  CHs0  unit  of  C)  of  the  isolated  C- 
fixing complexes used to construct the dose-response curve in Fig. 7 to react at 
room temperature for 20  min with 0.1  ml of various  dilutions  of the  water- 
soluble hapten epsilon-DNP-aminocaproic acid to produce a  variety of molar 
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FIG. 7.  Dose-response analysis of C-fixation by varying  amounts  of  C-fixing polymers 
pooled from the region of high specific activity. On the ordinate is the amount of polymer 
expressed in #g protein;  the abscissa is the number of OD541 units of complement fixed. 
(An OD541 unit is approximately equal to 2 CHs0 units.) 
excess ratios  of monovalent hapten.  After  the  initial  reaction  of monovalent 
hapten with complexes, the usual dilution  of complement was added and the 
entire mixture incubated overnight at 4°C. Appropriate controls, including those 
for effects introduced  by the hapten  alone,  were prepared.  It has previously 
been determined that anticomplementary effects were seen at a final concentra- 
tion of the hapten above 0.25  /~M/ml.  The remaining assay was performed as 
described previously. A 50 %  inhibition  of  C-fixation was achieved with a 25- 
fold molar excess with better than 90% inhibition by progressive increments. 
The finding that C-fixation by the isolated antigen-antibody complexes was 
specifically inhibited  by the  presence  of monovalent hapten  correlated  well 
with earlier ultracentrifugation studies  demonstrating that the heterogeneous 
polymeric forms  of  the  complexes  as  well  as  the  dimers  revert  to  the  IgG 
monomer form in the presence of monovalent hapten. 796  C  AND Ci FIXATION BY HAPTEN-ANTIBODY COMPLEXES 
The specificity of the quaternary structural  requirements  for C-fixation was 
also demonstrated by the sensitivity to even gentle heating at 37°C shown by 
C-fixing  complexes:  although  the  C-iLxing  efficiency of  a  particular  column 
fraction would remain stable for at least 1 wk if the samples were kept at 4°C, 
exposure to 37°C for an hour resulted in a  15 % loss of activity, and a 90% loss 
occurred  after  24  hr  of  incubation  (the  period  generally  recommended  for 
pepsin and papain digestions  of IgG). 
Study  of  Mechanism of C-Fixation by Soluble Complexes: Ci Fixation.--Ci 
fixation assays were performed on individual samples to determine if the frac- 
tions  evidencing  fixation  of whole  complement did  so on  the  basis  of initial 
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FtG. 8. Cl-fixation profile of fractionated hapten-antibody complexes: Sepharose 4B  gel 
in TCB-S. Every third tube assayed. Amount of C1 fixed (A) by individual fraction is ex- 
pressed as the difference in z-value between the  sample and  the  C1 control (centrifugation 
method; 15-min incubation at 30°C with EAC4). The solid line represents the protein con- 
centrations  of the  fractions. 
fixation of the first component with subsequent activation of the complement 
cascade. For these experiments hapten-antibody mixtures were fractionated  in 
TCB-S rather than TCB  to  enhance  Ci  fixation  and  reduce underestimation 
of fixation due to site-to-site transfer by Ci. 
The Ci-fixation profile is compared with  the elution profile in  Fig. 8; when 
this data is compared with Fig. 6, it is apparent that there is a direct correlation 
between the molecular species showing  Ci  fixation and those capable of fixing 
whole  complement. These conclusions based on relative elution  position were 
confirmed by electronmicroscopy. It is likely that  a  similar pattern would be 
found for C1  fixation (21,  22)  although  the efficiency of activation  of C1  by 
IgG complexes might affect the absolute values (10). 
The  kinetic  studies  supporting  the  choice  of  assay  system chosen  for  the 
column analysis are shown in Fig. 9.  Conventional t .... experiments were con- I-IYSLOP, DOIIRMASI-IKIN, GREEN, AND PORTER  797 
ducted  with  C]-fixing  complexes,  using  the  direct  stepwise  addition  of 
reagents in the method of Tshizaka et el. (22) and the modified system ultimately 
adopted which  employed a  centrifugation step to  separate  the  indicator  cells 
from the reaction system before reaction with  C2. Initial reaction of  Ci  with 
hapten-antibody  complexes  at  0°C  caused  no  appreciable difference  (23)  in 
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Fro.  9.  Kinetics of  C[-tixation  by  C-fixing  polymers.  A.  Direct  stepwise  addition  of 
reagents." abscissa indicates duration  of preliminary incubation  between  C1  and  polymers 
or buffer; results expressed as z values.  [z  =  -ln  (1  -- y), where y  =  per cent hemolysis]. 
Initial incubation of controls (triangles)  and polymer samples (circles) with C[ were studied 
at 0°C  (open symbols)  and 30°C (solid symbols), followed by 15-rain 30°C incubation with 
EAC4, 10-rain 30°C incubation with excess C2, and 90-min 37°C incubation with C-EDTA. 
B.  CentHfugation method: abscissa indicates duration of  reaction  between  EAC4 and mix- 
ture of C[ with polymers or buffer; results expressed as z-values. At t  =  0,  Ci  and EAC4 
were added to reagent flask containing  either active polymers or buffer, contents mixed, and 
1.5-ml  samples  removed  at  indicated  intervals,  cells  sedimented,  resuspended  in  1.0-ml 
TCB-S, treated 10 rain at 30°C with excess C2 and then 90 rain at 37°C with C-EDTA. 
Ci  fixation  over  an  initial  incubation  at  30°C  (Fig.  9A).  In  fact,  no  pre- 
liminary incubation  between complexes  and  Ci  was  necessary,  as  the  com- 
plexes appeared to compete favorably with  EAC4  for Ci  (Fig.  9B). The t~ 
for the reaction of 12-14 min was only definable with the centrifugation method, 
as the direct system employed a  15  min incubation step  with  EAC4 after the 
preliminary incubation of complexes with Ci. 
When a  dose-response curve was constructed using the two methods, shown 
in  Fig.  10,  it was  apparent  that dimers  had  no  significant  ability to  fix  Ci, 798  C  AND  C]  FIXATION  BY  IIAPTEN-ANTIBODY  COMPLEXES 
while  the large  complexes did  so in  direct proportion  to  concentration.  The 
scatter  of points  obtained  from the  current  centrifugation  method  assays in 
this figure and Fig. 8 make the data unsatisfactory for quantitative extrapola- 
tions such as calculating  moles  of  C]  fixed  per polymer  of  complex. Despite 
its technical imperfections, it was preferable to the direct addition system which 
appeared in 4°C overnight-experiments to cause an underestimation of number 
of  Ci  molecules  fixed,  presumably  due  to  generation  of  SAC42  sites  by 
fluid-phase complex-bound Ci. 
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Fro. 10. Dose-response analysis of C[ fixation by varying amounts of dinaers and C-lkxing 
(and Cl-fixing) polymers. Amount of C[ fixed expressed as difference in z value between 
sample and CI control; in relative protein concentration 100 =  15.6 #g protein of complex 
obtained by pooling samples from highly active region of TCB-S fractionation for C-fixing 
complexes and from main peak for dimer source. Cl-fixation analysis done by both  direct 
and centrifngation systems. 
DISCUSSION 
From the data  presented, it appears that  dimers and probably trimers of 
rabbit IgG antibody  linked by bivalent  hapten do not possess  the capacity to fix 
whole guinea pig complement while higher polymers do.  In view of present 
knowledge of rabbit IgG antibody populations, these results cannot reasonably 
be attributed to subclass differences in biological activity (24). It is likely that 
a difference in the ability to bind the first component of complement is the basis 
of this phenomenon, as the same pattern was found  for  Ci fixation. Since  the 
binding of the first component presumably is critically dependent on the physi- 
cal structure of the IgG polymers, these findings help to define the conditions 
required for this event. 
The minimal size of the predominant polymers in the fractions binding whole 
complement and Ci  most  efficiently appeared  to  be either  the tetramer,  the HYSLOP,  DOURMASHKIN,  GREEN~ AND  PORTER  799 
pentamer, or a slightly higher polymer. Only few trimers were found in these 
fractions and decreased efficiency was obtained with trimer-rich fractions, so it 
seems  unlikely that  the  trimer has significant complement-fixing activity. It 
was not possible to define an optimal or maximally efficient size because of the 
heterogeneity observed in the higher active fractions. 
The presence  of dimers  and  trimers  in  fractions  containing  chiefly larger 
polymers can be explained by the  tendency noted among the isolated larger 
polymers to dissociate and form smaller rings under a variety of normally mild 
conditions such as concentration by ultrafiltration, heating at 37°C, and even 
standing for prolonged periods at room temperature, in each case accompanied 
by a  reduction  in  C-fixing activity of  the  sample.  This  difficulty makes  it 
inefficient  to  attempt  improved  segregation  of  different-sized polymers  by 
refractionation until a system is  devised with a more stable hapten-antibody 
bond. 
Using a different system, Cohen (25)  concluded that a dimer of rabbit IgG 
was the minimal unit in a soluble antigen-antibody complex necessary to initiate 
whole complement fixation. From our experiments it seems clear that formation 
of tetramers or larger rings is a necessary condition for binding of C1 by hapten- 
antibody complexes. Since reversion to the monomeric state by simple addition 
of  monovalent hapten  to  the  polymers  abolished  complement  fixation,  the 
requisite structural features for C1 binding must be due to noncovalent bonds. 
Of the various possible configurational changes which may confer biological 
activity on the IgG polymers, an analysis of the dose-response experiments for 
whole complement fixation  and  Ci  fixation  eliminates  any  significant  con- 
tribution from aggregated polymers. In contrast to the  linear  proportionality 
observed in Fig.  7  between C-fixation and  complex concentration over a  20- 
fold range of protein concentrations, one would expect increasing efficiency of 
C-fixation  with  increased  concentration if  cooperative effects between poly- 
mers were a major factor in  C1  binding. This conclusion is supported by the 
linear  response  for  ci-fixation  by  the  large  polymers  (Fig.  10)  and  the 
inactivity of dimers over the same range of protein concentrations. 
At  present  it  is  not  possible  to  distinguish  between  contributions  to  the 
production of  an  active polymer by alterations  in  tertiary structure  of  the 
individual IgG molecule subunits and those arising from quaternary structural 
relationships  between  these  molecules.  It  is  possible  that  assumption  of  an 
appropriate  quaternary structure is  alone sufficient to provide the  necessary 
conditions for  C1 fixation in a manner analogous to  the requirement for more 
than one IgG molecule in formation of  a  Ci-fixing site  on  erythrocytes (10, 
26). 
Since  the  accumulated  evidence  assigns  the  primary  role  in  complement 
binding to the Fc portion of the molecule (1), it is possible that the ability to 
bind C1  is determined  solely by the number and relative positions of the Fc 800  C  AND  C]  FIXATION  BY  HAPTEN-ANTIBODY  COMPLEXES 
sections  within  the  various  polymers.  No  changes in  tertiary structure  need 
occur  if  the  relative  density  and  orientation  of  the  Fc  components  of  the 
various  polymers is  the  critical feature  controlling  C1  binding.  However,  in 
view of the inability of single molecules of IgM, containing five Fc fragments, 
to fix and activate complement except when bound to antigen, it seems probable 
that at least in the case of IgM some conformational change is required in addi- 
tion to a high density of C1  binding-sites. 
The  only  consistent  structural  difference between  the  active  and  inactive 
polymers that can be detected by electron microscopy is in the angle between 
the Fab arms of each IgG molecule. In the inactive polymers the angle is less 
than 60 °  , while in  the  active polymers it  lies  between  90 °  and  180 °  .  This  is 
consistent with the suggestion (27)  that opening up of the IgG molecule is ac- 
companied by conformational changes in the Fc fragment which  are required 
for fixation  of  complement.  The  extent  of  such  conformational changes  and 
possible methods for detecting them have been discussed in a recent review (20). 
SUMMARY 
Hapten-antibody complexes prepared at equivalence with the bivalent hapten 
bis-DNP-octamethylene-diamine and purified rabbit anti-DNP  antibody were 
fractionated by Sepharose gel-filtration and the fractions examined by electron 
microscopy.  Individual  fractions  were  tested  for  whole-complement  fixation 
and  Ci  fixation. Dimer forms did not  show this  type  of  biological  activity, 
while  fractions  containing  tetramers  and  larger  polymers  exhibited  both  C 
and Ci fixation, which could  be inhibited  by prior exposure of the  complexes 
to  the  univalent  hapten  epsilon-DNP-caproic  acid.  The  dose-response result 
indicated that the C-fixation observed was not due to interpolymeric coopera- 
tive effects. 
It was  concluded  that  in  the  generation  of  biological  activity  by  soluble 
antigen-antibody  complexes made  with  complement-fixing antibody,  quater- 
nary structural changes following specific combination with antigen may be as 
important  as  any tertiary  structural  alterations  that  occur in  the individual 
immunoglobulin molecule. 
The  authors are  indebted  to  Dr.  George Stevenson of  Oxford for a  gift  of rabbit anti- 
DNP  antibody  and  for  his  assistance  in  ultracentrifugation  studies  of  the  fraetionated 
polymers. 
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